Your Article Summary
Sanofi's intradermal flu vaccine -the way forward
PharmiWeb, 02/20/08
Recently Sanofi-Pasteur announced that they have filed with the European Medicines Agency (EMEA) their new influenza vaccine with an intradermal delivery (ID) system. The vaccine brings many possible benefits over current influenza vaccines. After observing many failed efforts to revolutionize flu vaccination, VacZine Analytics believes Sanofi’s product has the highest chance of dominating the future market.
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Surgical and minimally invasive treatments for Peyronie's disease
Current Opinion in Urology, 11/19/09
Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09
Derivation and Validation of the ASK-12 Adherence Barrier Survey
Annals of Pharmacotherapy, 10/15/09
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA drug approval intervals from 1997 to 2006: analysis and comparison during information technology implementation
International Journal of Electronic Healthcare , 12/01/09
Regulatory Update: GSK files Rotarix for prevention of rotavirus in Japan
GlaxoSmithKline, 12/01/09
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
Shire, 11/30/09
Article Search
Sponsor


See Latest Articles


